Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG

Approved

STANDARD

PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 24, 2023
Approval ID: cb685d2004ba40dc
Company: Teva B.V.
Type: Standard

Approval Details

Approval Id: cb685d2004ba40dc
Drug Cima Aemps Name: PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG
Register Number: 88857
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2023-05-24
Dosage Form: CÁPSULA DURA
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

Company Information

Pharmaceutical Company Name: Teva Pharma B.V.
Country Name: Netherlands
City Name: haarlem,noord-holland,country_nl
Address: Swensweg 5
Website: http://www.tevapharm.com

Active Ingredients

PREGABALINA

50 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 24, 2023

Approval ID

cb685d2004ba40dc

Type

Standard

Back to CIMA-AEMPS Approvals